Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference
-
Co-Diagnostics closes $7 million stock offering at $0.55 per share
-
Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
-
Maxim Group Downgrades Ryde Group (RYDE) to Hold
-
Guardian Metal Resources PLC Announces Final Results
-
XTI Aerospace, Inc. (XTIA) PT Lowered to $3 at Maxim Group
-
Co-Diagnostics prices $7 million stock offering at $0.55 per share
-
Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
-
PetVivo Holdings, Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference
-
BIO-key International raises $3.1 million through warrant exercise
-
BIO-key International Enters into $3.1 Million Warrant Inducement Transaction
-
SELLAS raises $31 million through warrant exercise by institutional investor
-
SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $31 Million in Gross Proceeds
-
Genenta Science prices $15 million share offering
-
Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares
-
Robin Energy prices $7.0 million registered direct offering
-
Robin Energy Ltd. Announces Pricing of $7.0 Million Registered Direct Offering
-
Rani Therapeutics raises $60.3 million in oversubscribed private placement
-
Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules
-
Hydreight Reports Corporate Update and Ranks #25 on Deloitte’s 2025 Technology Fast 50™
-
Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit
-
AIM ImmunoTech to Attend the 2025 Maxim Growth Summit
-
Empery Digital Releases New Investor Presentation
-
Maxim Group Downgrades Cryo-Cell International, Inc. (CCEL) to Hold
-
Perfect Corp to Present at Spartan Capital Securities' Second Annual Investor Conference
-
Perfect Corp to Present at Spartan Capital Securities' Second Annual Investor Conference
-
Castellum, Inc. to Attend the 2025 Maxim Growth Summit
-
Volatus Aerospace to Attend the 2025 Maxim Growth Summit
-
DeFi Technologies to Attend the 2025 Maxim Growth Summit
-
Rani Therapeutics raises $60.3 million in oversubscribed private placement
-
Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules
-
HCW Biologics to Participate in the 2025 Maxim Growth Summit
-
Edible Garden Enters into Warrant Exercise Transaction for $4.2 Million in Gross Proceeds
-
Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit
-
AmpliTech Group To Attend The 2025 MAXIM Growth Summit
-
Ur-Energy Participates in the 2025 Maxim Growth Summit in New York
-
NioCorp closes $150.2 million share offering at $9.34 per share
-
NioCorp Announces Closing of $150.2 Million Registered Direct Offering of Common Shares Priced At-the-Market
-
SEALSQ prices $200 million stock and warrant offering at premium
-
SEALSQ prices $200 million equity offering at premium to market
-
SEALSQ Announces Pricing of $200.0 Million Registered Direct Offering & Concurrent Private Placement of Ordinary Shares and Warrants
-
SEALSQ Announces Pricing of $200.0 Million Registered Direct Offering & Concurrent Private Placement of Ordinary Shares and Warrants
-
BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit
-
American Resources Corporation prices $40 million private placement
-
American Resources Corporation Announces Pricing of $40.0 Million Private Placement of Common Stock
-
Alpha Cognition, Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference
-
Aura Systems Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference
-
Genasys Inc. to Participate in 2025 Maxim Growth Summit
-
Alpha Cognition, Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference
-
Aura Systems Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference

